Overview

Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Multiple-center, multiple-dose, randomized, double-blind, six-arm, active- and placebo-controlled study in patients with moderate to severe post-surgical pain from elective orthopedic surgery with safety observed for a total of 30 hours post first dose.
Phase:
Phase 3
Details
Lead Sponsor:
Javelin Pharmaceuticals
Treatments:
Morphine